The Tri-Institutional MD-PhD Program (Tri-I) is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

Benjamin Jackson, a fifth year student in the Tri-I MD-PhD Program, has been awarded an F30 research grant by the National Institutes of Health (NIH). This award will support Mr.
On April 10, 2022, the Association of American Physicians (AAP) elected the group of scientists, physicians, and physician-scientists as new members. The group of honorees includes Tri-I MD-PhD Program alumni and faculty, including:Kiran Musunuru (Tri-I MD-PhD graduating class of 2004)Daniel Reich (Tri-I MD-PhD graduating class of 2001)Katharine Hsu (Tri-I MD-PhD graduating class of 1994 and current Tri-I MD-PhD Director)